avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Runx1
|
ENSMUSG00000022952.10 | runt related transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Runx1 | mm10_v2_chr16_-_92826004_92826080 | 0.87 | 5.0e-12 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.9 | 29.7 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
4.4 | 13.2 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
2.7 | 10.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
2.3 | 6.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.9 | 5.8 | GO:0002865 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
1.5 | 7.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
1.5 | 4.5 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
1.4 | 6.9 | GO:0070103 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.1 | 4.6 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.7 | 4.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 6.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.7 | 8.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.7 | 2.0 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.6 | 6.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.6 | 4.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.6 | 2.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 2.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.5 | 1.5 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 2.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 5.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.1 | GO:0021972 | corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.3 | 2.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 3.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 1.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 3.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 5.0 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 2.5 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.2 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 2.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.4 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.2 | 3.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.4 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.2 | 3.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 3.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 2.5 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.2 | 1.8 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 1.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 0.5 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.2 | 0.7 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 0.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.2 | GO:0060197 | cloacal septation(GO:0060197) |
0.2 | 2.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 3.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 2.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 3.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 2.8 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 2.8 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 1.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 2.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 2.6 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 9.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 5.4 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.9 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 2.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.0 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 1.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 1.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 1.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 1.4 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 3.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 2.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 1.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 29.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 6.0 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.9 | 2.8 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.8 | 10.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 2.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 5.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 5.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 4.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 3.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 13.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 2.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0097059 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 1.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 6.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 8.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.9 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 3.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 5.7 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 1.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 4.3 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 3.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 4.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 2.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 5.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 3.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 4.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 3.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 2.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 10.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.8 | 4.6 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.7 | 2.8 | GO:0050436 | microfibril binding(GO:0050436) |
0.6 | 7.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 4.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 2.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) bradykinin receptor binding(GO:0031711) |
0.5 | 7.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.5 | 29.7 | GO:0004601 | peroxidase activity(GO:0004601) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 2.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 13.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 2.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 5.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 1.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 8.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 3.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 5.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 3.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.1 | GO:0043237 | GTPase inhibitor activity(GO:0005095) laminin-1 binding(GO:0043237) Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 3.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 3.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 3.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 3.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 3.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 4.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 8.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 1.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 6.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 2.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 2.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 3.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 1.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 2.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 1.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 34.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 5.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 16.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 14.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 6.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 6.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 2.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 2.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 7.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 5.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 4.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 6.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 4.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 4.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 5.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 5.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 2.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 3.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 3.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 2.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 8.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 3.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 4.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 2.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |